National Cancer Institute , Thailand.
Ratchathewi, Bangkok, 10400, Thailand
NCT Number: NCT01935739
The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.
Looking for future studies?
Notify Me25 year–70 year
Female
Observational
Ratchathewi, Bangkok, 10400, Thailand
HER2/neu status of primary breast tumor and axillary lymph nodes were tested by IHC staining. In the cases of equivocal result of IHC, FISH test were performed.
The result of HER2/neu status between primary breast tumor and axillary lymph node were analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 1 year
Association of HER2/neu status between primary breast tumor and axillary lymph nodes was analyzed by using the χ2 test
National Cancer Institute, Thailand
Other Gov
Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01943032
Breast Diseases, Breast Neoplasms
Ratchathewi, Bangkok, Thailand
View Trial DetailsNCT05181722
Breast Cancer, Breast Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07760714
Breast Cancer, Breast Diseases
East Hanover, New Jersey, United States
View Trial DetailsNCT07764653
Breast Cancer, Breast Diseases
Beijing, Beijing Municipality, China
View Trial Details